This report highlights a select few collaborations with IFPMA companies, and details the innovative methods in which these collaborations are working to meet urgent global supply needs.

IFPMA member companies are at the forefront of the global effort to develop a safe
and effective COVID-19 vaccine and scale up manufacturing to ensure equitable
access to people around the world. In less than a year, several vaccines candidates
have been approved or are in advanced Phase III clinical trials with encouraging
results. An impressive and unprecedented manufacturing scale-up is also taking
place.